# AKOVAZ
> **NDA208289** · New Drug Application · Sponsor: EXELA PHARMA · Approved 2016-04-29
## Drug
- **FDA Application Number:** NDA208289
- **Application type:** New Drug Application
- **Brand name:** AKOVAZ
- **Generic name:** EPHEDRINE SULFATE
- **Active ingredients:** EPHEDRINE SULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EXELA PHARMA
- **Manufacturer:** Exela Pharma Sciences, LLC
- **First approval:** 2016-04-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208289)
---
*AI Analytics · CC0 1.0*